• MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Urology Times. All rights reserved.

Around the Practice

EP. 1: Rate of BCR in Prostate Cancer 
EP. 2: Best Practices for Monitoring After Definitive Therapy in Prostate Cancer
EP. 3: Defining PSA Nadir After Definitive Therapy in Prostate Cancer 
EP. 4: Considerations for Initiating ADT After Biochemical Recurrence in Prostate Cancer 
EP. 5: Case 1: 58-Year-Old Man 6 Months Post-Radical Prostatectomy 
EP. 6: Imaging Modalities for Evaluating Biochemical Recurrence in Prostate Cancer 
EP. 1: Penile/Urethral cancer with inguinal adenopathy
EP. 2: Non-muscle Invasive bladder/urothelial Cancer
EP. 1: Localized, high-risk prostate cancer with oligometastasis at diagnosis
EP. 2: Incidentally discovered adrenal mass
EP. 1: Around the Practice: January 20, 2021
EP. 1: Metastatic Castrate Sensitive Prostate Cancer
EP. 2: Non-Metastatic Castrate Resistant Prostate Cancer
EP. 3: De novo Metastatic Renal Cell Carcinoma